Q9Y5B0 (CTDP1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 123.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: RNA polymerase II subunit A C-terminal domain phosphatase EC=3.1.3.16 Alternative name(s): TFIIF-associating CTD phosphatase | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 961 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Processively dephosphorylates 'Ser-2' and 'Ser-5' of the heptad repeats YSPTSPS in the C-terminal domain of the largest RNA polymerase II subunit. This promotes the activity of RNA polymerase II. Plays a role in the exit from mitosis by dephosphorylating crucial mitotic substrates (USP44, CDC20 and WEE1) that are required for M-phase-promoting factor (MPF)/CDK1 inactivation. Ref.14 |
| Catalytic activity | A phosphoprotein + H2O = a protein + phosphate. |
| Subunit structure | Homodimer. Interacts with GTF2F1. Interacts with WDR77, SNRPB and SNRNP70. Ref.1 Ref.6 |
| Subcellular location | Nucleus. Cytoplasm › cytoskeleton › centrosome. Cytoplasm › cytoskeleton › spindle. Cytoplasm › cytoskeleton › spindle pole. Midbody. Note: Found at centrosomes in prometaphase, at spindle and spindle poles in metaphase and at spindle midzone and midbody in anaphase and telophase-G1 respectively. Ref.14 |
| Tissue specificity | Ubiquitously expressed. Isoform 3 is expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and placenta. Ref.1 |
| Post-translational modification | Phosphorylated. In the presence of TFIIF, the phosphorylated form has an increased CTD phosphatase activity. The phosphorylation is required for the physical interaction with GTF2F1. Ref.7 |
| Involvement in disease | Congenital cataracts, facial dysmorphism, and neuropathy (CCFDN) [MIM:604168]: An autosomal recessive developmental disorder characterized by a complex clinical phenotype with seemingly unrelated features involving multiple organs and systems. Developmental abnormalities include congenital cataracts and microcorneae, hypomyelination of the peripheral nervous system, impaired physical growth, delayed early motor and intellectual development, facial dysmorphism and hypogonadism. Central nervous system involvement, with cerebral and spinal cord atrophy, may be the result of disrupted development with superimposed degenerative changes. Affected individuals are prone to severe rhabdomyolysis after viral infections and to serious complications related to general anesthesia (such as pulmonary edema and epileptic seizures). |
| Sequence similarities | Contains 1 BRCT domain. Contains 1 FCP1 homology domain. |
Ontologies
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9Y5B0-1) Also known as: Fcp1; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9Y5B0-2) Also known as: Fcp1a; The sequence of this isoform differs from the canonical sequence as follows: 1-119: Missing. 807-961: AVPPPQPQMF...ALEAELNDLM → WTTSLEKAAT...AGGPEATRGS | ||||||
| Isoform 3 (identifier: Q9Y5B0-3) Also known as: Fcp1b; The sequence of this isoform differs from the canonical sequence as follows: 1-119: Missing. | ||||||
| Isoform 4 (identifier: Q9Y5B0-4) The sequence of this isoform differs from the canonical sequence as follows: 807-961: AVPPPQPQMF...ALEAELNDLM → WTTSLEKAAT...AGGPEATRGS |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||
Molecule processing | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 961 | 961 | RNA polymerase II subunit A C-terminal domain phosphatase | PRO_0000212564 | ||||||||||
Regions | ||||||||||||||
| Domain | 178 – 344 | 167 | FCP1 homology | |||||||||||
| Domain | 629 – 728 | 100 | BRCT | |||||||||||
| Compositional bias | 455 – 478 | 24 | Ser-rich | |||||||||||
| Compositional bias | 577 – 582 | 6 | Poly-Glu | |||||||||||
Amino acid modifications | ||||||||||||||
| Modified residue | 674 | 1 | Phosphoserine Ref.11 | |||||||||||
| Modified residue | 780 | 1 | N6-acetyllysine Ref.10 | |||||||||||
| Modified residue | 869 | 1 | Phosphoserine Ref.8 Ref.11 | |||||||||||
| Modified residue | 872 | 1 | Phosphoserine Ref.11 Ref.13 | |||||||||||
Natural variations | ||||||||||||||
| Alternative sequence | 1 – 119 | 119 | Missing in isoform 2 and isoform 3. | VSP_009864 | ||||||||||
| Alternative sequence | 807 – 961 | 155 | AVPPP…LNDLM → WTTSLEKAATTATARRGGLR SRRRSPSPGSQGPAGSGRSG HLRPARGARQGAGGPEATRG S in isoform 2 and isoform 4. | VSP_009865 | ||||||||||
| Natural variant | 282 | 1 | S → F. Corresponds to variant rs4799078 [ dbSNP | Ensembl ]. | VAR_060440 | ||||||||||
| Natural variant | 340 | 1 | T → M. Corresponds to variant rs2279103 [ dbSNP | Ensembl ]. | VAR_018264 | ||||||||||
| Natural variant | 519 | 1 | P → H. Corresponds to variant rs557503 [ dbSNP | Ensembl ]. | VAR_060441 | ||||||||||
| Natural variant | 755 | 1 | L → S. Corresponds to variant rs34967023 [ dbSNP | Ensembl ]. | VAR_032763 | ||||||||||
Experimental info | ||||||||||||||
| Sequence conflict | 61 | 1 | S → A in AAD42088. Ref.2 | |||||||||||
| Sequence conflict | 61 | 1 | S → A in AAH63447. Ref.5 | |||||||||||
| Sequence conflict | 157 | 1 | P → A in AAC64549. Ref.1 | |||||||||||
| Sequence conflict | 281 | 1 | F → I in AAH52576. Ref.5 | |||||||||||
| Sequence conflict | 305 | 1 | E → K in AAD42088. Ref.2 | |||||||||||
| Sequence conflict | 390 | 1 | A → P in AAC64549. Ref.1 | |||||||||||
| Sequence conflict | 478 | 1 | S → T in AAC64549. Ref.1 | |||||||||||
| Sequence conflict | 486 – 487 | 2 | KP → NA in AAC64549. Ref.1 | |||||||||||
| Sequence conflict | 504 – 505 | 2 | EP → DA in AAC64549. Ref.1 | |||||||||||
| Sequence conflict | 513 | 1 | L → V in AAC64549. Ref.1 | |||||||||||
| Sequence conflict | 656 – 657 | 2 | EH → DD in AAC64549. Ref.1 | |||||||||||
| Sequence conflict | 896 – 900 | 5 | ERTLG → GADAR in AAD42088. Ref.2 | |||||||||||
Secondary structure | ||||||||||||||
Helix Strand Turn | ||||||||||||||
| Helix | 586 – 598 | 13 | ||||||||||||
| Helix | 945 – 956 | 12 | ||||||||||||
| Turn | 957 – 959 | 3 | ||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "FCP1, the RAP74-interacting subunit of a human protein phosphatase that dephosphorylates the carboxyl-terminal domain of RNA polymerase IIO." Archambault J., Pan G., Dahmus G.K., Cartier M., Marshall N., Zhang S., Dahmus M.E., Greenblatt J. J. Biol. Chem. 273:27593-27601(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), TISSUE SPECIFICITY, INTERACTION WITH GTF2F1. Tissue: Placenta. |
| [2] | "A protein phosphatase functions to recycle RNA polymerase II." Cho H., Kim T.-K., Mancebo H., Lane W.S., Flores O., Reinberg D. Genes Dev. 13:1540-1552(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Cervix carcinoma. |
| [3] | "DNA sequence and analysis of human chromosome 18." Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J. Lander E.S.Nature 437:551-555(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 88-961 (ISOFORM 1), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 303-961 (ISOFORM 3/4). Tissue: Colon, Lymph and Ovary. |
| [6] | "The FCP1 phosphatase interacts with RNA polymerase II and with MEP50 a component of the methylosome complex involved in the assembly of snRNP." Licciardo P., Amente S., Ruggiero L., Monti M., Pucci P., Lania L., Majello B. Nucleic Acids Res. 31:999-1005(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH WDR77; SNRPB AND SNRNP70. |
| [7] | "The C-terminal domain phosphatase and transcription elongation activities of FCP1 are regulated by phosphorylation." Friedl E.M., Lane W.S., Erdjument-Bromage H., Tempst P., Reinberg D. Proc. Natl. Acad. Sci. U.S.A. 100:2328-2333(2003) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-869, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [10] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-780, MASS SPECTROMETRY. |
| [11] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-674; SER-869 AND SER-872, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [13] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-872, MASS SPECTROMETRY. |
| [14] | "Fcp1-dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit." Visconti R., Palazzo L., Della Monica R., Grieco D. Nat. Commun. 3:894-894(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [15] | "Molecular mechanism of recruitment of TFIIF-associating RNA polymerase C-terminal domain phosphatase (FCP1) by transcription factor IIF." Kamada K., Roeder R.G., Burley S.K. Proc. Natl. Acad. Sci. U.S.A. 100:2296-2299(2003) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 944-961 IN COMPLEX WITH GTF2F1. |
| [16] | "Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome." Varon R., Gooding R., Steglich C., Marns L., Tang H., Angelicheva D., Yong K.K., Ambrugger P., Reinhold A., Morar B., Baas F., Kwa M., Tournev I., Guerguelcheva V., Kremensky I., Lochmueller H., Muellner-Eidenboeck A., Merlini L. Kalaydjieva L.Nat. Genet. 35:185-189(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN CCFDN. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF081287 mRNA. Translation: AAC64549.1. AF154115 mRNA. Translation: AAD42088.1. AC021594 Genomic DNA. No translation available. AC068473 Genomic DNA. No translation available. CH471117 Genomic DNA. Translation: EAW66631.1. BC015010 mRNA. Translation: AAH15010.1. BC052576 mRNA. Translation: AAH52576.1. BC063447 mRNA. Translation: AAH63447.1. | ||||||||||||||||||||||||
| IPI | IPI00410256. IPI00410257. IPI00410258. IPI01008810. | ||||||||||||||||||||||||
| RefSeq | NP_001189433.1. NM_001202504.1. NP_004706.3. NM_004715.4. NP_430255.2. NM_048368.3. | ||||||||||||||||||||||||
| UniGene | Hs.465490. Hs.734021. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| DisProt | DP00177. | ||||||||||||||||||||||||
| ProteinModelPortal | Q9Y5B0. | ||||||||||||||||||||||||
| SMR | Q9Y5B0. Positions 168-344, 585-728. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| DIP | DIP-41788N. | ||||||||||||||||||||||||
| IntAct | Q9Y5B0. 2 interactions. | ||||||||||||||||||||||||
| MINT | MINT-275991. | ||||||||||||||||||||||||
| STRING | 9606.ENSP00000299543. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | Q9Y5B0. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 46396052. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | Q9Y5B0. | ||||||||||||||||||||||||
| PRIDE | Q9Y5B0. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| DNASU | 9150. | ||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000075430; ENSP00000075430; ENSG00000060069. ENST00000299543; ENSP00000299543; ENSG00000060069. | ||||||||||||||||||||||||
| GeneID | 9150. | ||||||||||||||||||||||||
| KEGG | hsa:9150. | ||||||||||||||||||||||||
| UCSC | uc002lnh.2. human. uc002lni.2. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 9150. | ||||||||||||||||||||||||
| GeneCards | GC18P077494. | ||||||||||||||||||||||||
| HGNC | HGNC:2498. CTDP1. | ||||||||||||||||||||||||
| HPA | CAB032641. HPA040394. | ||||||||||||||||||||||||
| MIM | 604168. phenotype. 604927. gene. | ||||||||||||||||||||||||
| neXtProt | NX_Q9Y5B0. | ||||||||||||||||||||||||
| Orphanet | 48431. Congenital cataracts - facial dysmorphism - neuropathy. | ||||||||||||||||||||||||
| PharmGKB | PA27001. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | COG5190. | ||||||||||||||||||||||||
| HOGENOM | HOG000112039. | ||||||||||||||||||||||||
| HOVERGEN | HBG051213. | ||||||||||||||||||||||||
| InParanoid | Q9Y5B0. | ||||||||||||||||||||||||
| KO | K15732. | ||||||||||||||||||||||||
| OMA | EAPDIRK. | ||||||||||||||||||||||||
| OrthoDB | EOG4HMJ8T. | ||||||||||||||||||||||||
| PhylomeDB | Q9Y5B0. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Reactome | REACT_116125. Disease. REACT_1788. Transcription. REACT_1892. Elongation arrest and recovery. REACT_71. Gene Expression. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| Bgee | Q9Y5B0. | ||||||||||||||||||||||||
| CleanEx | HS_CTDP1. | ||||||||||||||||||||||||
| Genevestigator | Q9Y5B0. | ||||||||||||||||||||||||
| GermOnline | ENSG00000060069. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| Gene3D | 3.40.50.1000. 2 hits. | ||||||||||||||||||||||||
| InterPro | IPR001357. BRCT_dom. IPR015388. FCP1_C. IPR011947. FCP1_euk. IPR023214. HAD-like_dom. IPR004274. NIF. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF09309. FCP1_C. 1 hit. PF03031. NIF. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SMART | SM00292. BRCT. 1 hit. SM00577. CPDc. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SUPFAM | SSF52113. BRCT. 1 hit. SSF56784. HAD-like_dom. 1 hit. | ||||||||||||||||||||||||
| TIGRFAMs | TIGR02250. FCP1_euk. 1 hit. | ||||||||||||||||||||||||
| PROSITE | PS50172. BRCT. 1 hit. PS50969. FCP1. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| ChiTaRS | CTDP1. human. | ||||||||||||||||||||||||
| EvolutionaryTrace | Q9Y5B0. | ||||||||||||||||||||||||
| GenomeRNAi | 9150. | ||||||||||||||||||||||||
| NextBio | 34327. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | CTDP1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9Y5B0 Secondary accession number(s): A8MY97 Q9Y6F5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 18 Human chromosome 18: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
